## BBY: Best Buy Co., Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.99 indicates fundamental undervaluation. Quality metrics strong (ROE 22%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($68.25)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Brown Advisory Inc. Lowers Stake in Best Buy Co., Inc. $BBY**
- Source: MarketBeat | 20251208T090816 | Neutral | Relevance: 99%
-  Brown Advisory Inc. reduced its stake in Best Buy Co., Inc. (NYSE:BBY) by 25.6% during the second quarter, selling 71,251 shares and now owning 206,813 shares valued at approximately $13.88 million. Despite this, Best Buy exceeded Q2 earnings expectations with $1.40 EPS and $9.67 billion revenue, and analysts currently rate the stock as "Hold" with an average price target of $84.74. The company also announced a quarterly dividend of $0.95, resulting in a 5.1% yield, and insiders have sold a significant amount of shares in the past three months.

**2. Best Buy Co., Inc. $BBY Position Lessened by Marshall Wace LLP**
- Source: MarketBeat | 20251208T113958 | Neutral | Relevance: 99%
-  Marshall Wace LLP significantly reduced its stake in Best Buy Co., Inc. (NYSE:BBY) by 68.8% in Q2, selling over 1.1 million shares. Despite this, other hedge funds increased their positions, and 80.96% of the stock is held by institutional investors. Best Buy recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend.

**3. 1832 Asset Management L.P. Buys Shares of 21,371 Best Buy Co., Inc. $BBY**
- Source: MarketBeat | 20251207T080720 | Somewhat-Bullish | Relevance: 99%
-  1832 Asset Management L.P. initiated a new position in Best Buy Co., Inc. (NYSE:BBY) by purchasing 21,371 shares valued at approximately $1.435 million in the second quarter. Other institutional investors also adjusted their stakes in BBY, with 80.96% of the stock owned by hedge funds and institutions. Best Buy recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend of $0.95 per share.

**4. Evercore ISI Adjusts Price Target on Best Buy to $80 From $85, Maintains In Line Rating**
- Source: marketscreener.com | 20251209T113022 | Neutral | Relevance: 98%
-  Evercore ISI has lowered its price target for Best Buy (BBY) to $80 from $85, while maintaining an "In Line" rating for the stock. This adjustment comes amidst other recent analyst revisions and news, including Best Buy's appointment of Dylan Jadeja to its Board of Directors and various reports on holiday shopping trends. The company specializes in the retail distribution of consumer electronic and entertainment products across the United States and Canada.

**5. Invesco Ltd. Acquires 621,863 Shares of Best Buy Co., Inc. $BBY**
- Source: MarketBeat | 20251207T104545 | Somewhat-Bullish | Relevance: 98%
-  Invesco Ltd. increased its stake in Best Buy Co., Inc. by 15.8% in Q2, acquiring 621,863 shares to own a total of 4,548,650 shares valued at approximately $305.35 million. Best Buy reported strong Q2 earnings, beating analyst expectations, and set favorable FY2026 guidance, while also declaring a quarterly dividend of $0.95. Despite recent insider selling, institutional investors hold a significant portion of the company's stock.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 7, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Evercore ISI Gr | $80 | $85 | -6% |
| 2025-11-26 | Truist Securiti | $84 | $79 | +6% |
| 2025-11-26 | Barclays | $81 | $74 | +9% |
| 2025-11-26 | UBS | $96 | $93 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Evercore ISI Gr | main | In-Line |
| 2025-11-26 | Truist Securiti | main | Hold |
| 2025-11-26 | Barclays | main | Equal-Weight |
| 2025-11-26 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 8 ($109.58M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Blackrock Inc.: 11.8% (-0.5%)
- Vanguard Group Inc: 11.4% (+2.4%)
- State Street Corpora: 6.3% (-2.2%)
- JPMORGAN CHASE & CO: 4.5% (+74.1%)
- Charles Schwab Inves: 3.5% (+3.6%)

### Key Risks

1. Heavy insider selling: $110M sold (8 transactions in 90 days).
2. Near-term weakness: 6.0% below SMA50 despite long-term uptrend.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 7 raises (avg +7%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.99 indicates undervaluation relative to growth. Quality metrics strong (ROE 22%). Analyst sentiment positive (7 raises, avg +7%). Insider selling cluster ($109.6M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $15.5B |
| Beta | 1.39 |
| 52W Range | $54.99 - $91.68 |
| Short Interest | 7.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.99 |
| Forward P/E | 10.8 |
| Current P/E | 11.5 |
| YoY Growth | 6.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -5.6% (minimal 5-day change). Below STRENGTH zone by 9.6pp (needs >4.0% for momentum thesis). AM_20 at -3.5% indicates price below own 20MA trend. Underperforming sector by 4.7pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.00x) but short-term weakness (below SMA20).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.61% (CS: 14) | Weak |
| RSI_14 | 39.4 | Neutral |
| MACD Histogram | -0.41 | Bearish |
| vs SMA20 | 0.965x | Below |
| vs SMA50 | 0.940x | Below |
| vs SMA200 | 1.005x | Above |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $73.17
- **Stop Loss:** $68.25 (6.7% risk)
- **Target:** $83.01 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 101
- **Position Value:** $7,390.17
- **Portfolio %:** 7.39%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-03-03 (Est: $2.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.31 | $1.40 | +6.7% |
| 2025Q3 | $1.22 | $1.28 | +4.5% |
| 2025Q2 | $1.10 | $1.15 | +5.0% |
| 2025Q1 | $2.41 | $2.58 | +7.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*